China successfully developed the world's first single-generation combined artificial liver

Recently, the national 863 plan and Guangdong key technology projects —-the world's first "new generation of human cells combined bioartificial liver" in the development of Pearl River hospital, Southern Medical University, and received 9 national patents.

Currently, the project has been successfully produced the first new bioartificial liver prototype, is about to enter the clinical trial phase.

Pearl River hospital and Gall (section II), "gaoyi is expected in the next three to five years, this machine will be able to enter the clinical phases, a real ' life-saving machine '.

A capacity of about 3 liters of bioreactor for about nine to training 10 th to 10 th 10 a liver cells for a patient to receive at least 3 to 5 days of treatment, cost about 1 to 2 million.

For hepatitis and liver failure patients, at present, treatment is mainly a medical drug treatment and liver transplantation, but drug treatment results are unsatisfactory, the fatality rate is as high as 80% to 90%.

Today, China every year, about 30 to 50 million patients eventually died of liver failure.